?:authorAffiliation
|
-
[\'Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands. a.dinmohamed@iknl.nl.\', \'Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. a.dinmohamed@iknl.nl.\', \'Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.\', \'Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands.\', \'Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.\', \'Department of Pathology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.\', \'Laboratory for Pathology Dordrecht, Dordrecht, The Netherlands.\', \'Divisions of Diagnostic Oncology and Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.\', \'Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.\', \'Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.\', \'Dutch Expert Centre for Screening, Nijmegen, The Netherlands.\', \'Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.\', \'Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.\', \'Department of Oral and Maxillofacial Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.\', \'PALGA Foundation, Houten, The Netherlands.\', \'Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.\', \'Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands. s.siesling@iknl.nl.\', \'Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands. s.siesling@iknl.nl.\']
|